CureVac-话题@MedSci

#CureVac#

6篇内容 | 779人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1493260, encodeId=84611493260d3, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, objectTitle=德国CureVac新冠疫苗三期临床试验有效性仅为47%，病毒变异疫苗开发挑战增加, objectType=article, longId=212858, objectId=6bb6212858c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bb6212858c0, replyNumber=0, likeNumber=40, createdTime=2021-06-19, rootId=0, userName=doctor-chen9585, userId=31089012323, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bb6212858c0, moduleTitle=德国CureVac新冠疫苗三期临床试验有效性仅为47%，病毒变异疫苗开发挑战增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bb6212858c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493259, encodeId=fcf6149325989, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, objectTitle=葛兰素史克（GSK）和CureVac制造针对新变体的COVID-19疫苗, objectType=article, longId=206778, objectId=9be9206e7855, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be9206e7855, replyNumber=0, likeNumber=29, createdTime=2021-02-06, rootId=0, userName=doctor-chen9585, userId=31089012323, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be9206e7855, moduleTitle=葛兰素史克（GSK）和CureVac制造针对新变体的COVID-19疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be9206e7855)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493258, encodeId=69331493258eb, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, objectTitle=CureVac的新冠COVID-19疫苗可在标准冰箱温度下保持稳定3个月, objectType=article, longId=203479, objectId=51112034e9ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51112034e9ff, replyNumber=0, likeNumber=30, createdTime=2020-11-18, rootId=0, userName=doctor-chen9585, userId=31089012323, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51112034e9ff, moduleTitle=CureVac的新冠COVID-19疫苗可在标准冰箱温度下保持稳定3个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51112034e9ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493257, encodeId=29d4149325ec7, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, objectTitle=CureVac的COVID-19候选疫苗可触发免疫反应, objectType=article, longId=194238, objectId=482b194238a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=482b194238a0, replyNumber=0, likeNumber=34, createdTime=2020-05-17, rootId=0, userName=doctor-chen9585, userId=31089012323, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=482b194238a0, moduleTitle=CureVac的COVID-19候选疫苗可触发免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=482b194238a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493256, encodeId=db84149325603, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, objectTitle=盖茨基金会新战略：5200万美元投资德国疫苗公司CureVac, objectType=article, longId=48042, objectId=e1614804284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1614804284, replyNumber=0, likeNumber=44, createdTime=2015-03-13, rootId=0, userName=doctor-chen9585, userId=31089012323, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1614804284, moduleTitle=盖茨基金会新战略：5200万美元投资德国疫苗公司CureVac, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1614804284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493255, encodeId=e7c01493255a9, content=<a href='/topic/show?id=03d05504ba' target=_blank style='color:#2F92EE;'>#CureVac#</a>, objectTitle=赛诺菲巴斯德与德国CureVac加强在mRNA领域研究合作, objectType=article, longId=37478, objectId=8b353e47825, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b353e47825, replyNumber=0, likeNumber=41, createdTime=2014-07-09, rootId=0, userName=doctor-chen9585, userId=31089012323, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b353e47825, moduleTitle=赛诺菲巴斯德与德国CureVac加强在mRNA领域研究合作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b353e47825)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CureVac

2020-05-29

doctor-chen9585 (审核中...)

前往app查看评论内容

#CureVac#

德国CureVac新冠疫苗三期临床试验有效性仅为47%，病毒变异疫苗开发挑战增加

2021-06-19

doctor-chen9585 (审核中...)

前往app查看评论内容

#CureVac#

葛兰素史克（GSK）和CureVac制造针对新变体的COVID-19疫苗

2021-02-06

doctor-chen9585 (审核中...)

前往app查看评论内容

#CureVac#

CureVac的新冠COVID-19疫苗可在标准冰箱温度下保持稳定3个月

2020-11-18

doctor-chen9585 (审核中...)

前往app查看评论内容

#CureVac#

CureVac的COVID-19候选疫苗可触发免疫反应

2020-05-17

doctor-chen9585 (审核中...)

前往app查看评论内容

#CureVac#

盖茨基金会新战略：5200万美元投资德国疫苗公司CureVac

2015-03-13

doctor-chen9585 (审核中...)

前往app查看评论内容

#CureVac#

赛诺菲巴斯德与德国CureVac加强在mRNA领域研究合作

2014-07-09

科室
- - 订阅+
  - 更多科室
工具
服务